Medications

FDA approves Dupixent for chronic obstructive pulmonary disease

The U.S. Food and Drug Administration has approved Regeneron's Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic ...

Diseases, Conditions, Syndromes

Wearable lung patch uses deep learning to detect asthma and COPD

Wheezing, a high-pitched whistling sound, is a common indicator of chronic respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD), due to inflammation and swelling of the airways.

page 2 from 40